Therapeutics: Tumor necrosis factor receptor superfamily member 21 (TNFRSF21; DR6); receptor-interacting serine-threonine kinase 1 (RIPK1; RIP1); RIPK3 (RIP3)

Cell culture and mouse studies suggest inhibiting the necroptosis-related proteins RIPK1, RIPK3 or TNFRSF21 could help treat metastatic breast, lung, melanoma and other metastatic cancers. In co-cultu...